ArticleFolia microbiologica2026
Comprehensive global-scale evaluation of the COVID-19 pandemic associated with 234 countries, territories, and sub-national locations during 2020-2024.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Monocytes in pneumonia: Functional plasticity and innate memory (Review).International journal of molecular medicine · 2026Review
- COVID-19 Vaccination Refusal and Non-Uptake Among People Living with HIV in the United States.Journal of community health · 2026Review
- CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4Frontiers in immunology · 2026Article
- Genetic Risk of Different Populations in COVID-19 Susceptibility and Severity.Infection and drug resistance · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Comprehensive estimation of COVID-19, including infection, death, excess mortality, case fatality rate (CFR), and infection fatality rate (IFR), is essential for understanding the pandemic's pattern. The location-specific estimates of infection, death, and excess mortality of COVID-19 from January 1, 2020, to February 11, 2024, and we have cumulative infections and cumulative deaths worldwide. Using the WHO dataset and Our World in Data, we estimated infection, mortality, excess mortality, CFR, and IFR in 234 countries and territories during COVID-19. We found a cumulative 0.774631 billion infections and 7.031 million deaths worldwide. The global highest infection peak was noted on December 25, 2022, with 42.5 million infection cases. Similarly, considering region-wise infection, cumulative infection was highest in Europe (428.4 M) and lowest in Africa (9.6 M). The global highest death peak was noted on January 24, 2021, with 103.7 K million deaths; this might be due to the spread of the Delta variant in some regions of Asia. Similarly, region-wise mortality was calculated. The considerable excess mortality pattern was noted in Europe, South America, and North America. Decreasing trends in excess mortality were noted in Oceania, Asia, and Africa. Our studies could be beneficial in formulating public health strategies and implementing policies about those regions, which are crucial to global health and will help future pandemics.
Indexed as
Identifiers
40736939What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.